Sphera Funds Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Sphera Funds Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-74,500	Closed	-$2.23M	–	159
2017 Q2	$2.23M	Buy	+74,500	New	+$1.93M	0.38%	78
2017 Q1	–	Sell	-175,951	Closed	-$3.91M	–	138
2016 Q4	$3.91M	Sell	175,951 -77,562	-31%	-$1.45M	0.99%	27
2016 Q3	$4.69M	Sell	253,513 -5,000	-2%	-$86.7K	0.76%	30
2016 Q2	$4.2M	Buy	258,513 +92,154	+55%	+$1.55M	1.09%	24
2016 Q1	$2.35M	Buy	+166,359	New	+$2.25M	0.51%	39
2015 Q4	–	Sell	-85,000	Closed	-$1.76M	–	153
2015 Q3	$1.76M	Buy	+85,000	New	+$1.74M	0.22%	101

Other funds holding NDRM

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CFIC

City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Sphera Funds Management's NDRM Position: Q3 2017 in Review

Sphera Funds Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2017, closing a stake of 74,500 shares — an estimated $2.23M sold.

Sphera Funds Management first reported a position in NDRM in Q3 2015 and held it in 6 quarters. The position peaked at $4.69M in Q3 2016. 81 funds tracked by Wall St. Rank hold NDRM as of Q3 2017.

Sphera Funds Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Sphera Funds Management sold 74,500 NeuroDerm Ltd. Ordinary Shares shares in Q3 2017, an estimated $2.23M.
Sphera Funds Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 6 quarters.
Sphera Funds Management's NeuroDerm Ltd. Ordinary Shares position peaked at $4.69M in Q3 2016.
81 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2017.

Based on Sphera Funds Management's 13F filing for Q3 2017, filed 9 Nov 2017.